Sort   by:  
 Page size 

The routine clinical diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely restricted to real-time reverse transcription polymerase chain reaction (RT-qPCR), and tests that detect SARS-CoV-2 nucleocapsid antigen. Given the diagnostic delay and suboptimal sensitivity...

2024-08-26 | MTBLS6739 | MetaboLights
Severe acute respiratory syndrome coronavirus (SARS-CoV) causes a respiratory disease leading to death in 10% of the infected people. A mouse adapted SARS-CoV lacking the envelope (E) protein (rSARS-CoV-MA15-?E) is attenuated in vivo. To identify E protein domains and host responses that contribute ...
ORGANISM(S): Mus musculus 
Respiratory failure and mortality from COVID-19 result from virus- and inflammation-induced lung tissue damage. The intestinal microbiome and associated metabolites are implicated in immune responses to respiratory viral infections, however their impact on progression of severe COVID-19 remains uncl...
2023-05-02 | MTBLS5288 | MetaboLights
Severe acute respiratory syndrome coronavirus 2 Genome sequencing
Severe acute respiratory syndrome coronavirus 2 Genome sequencing
Severe acute respiratory syndrome coronavirus 2 Genome sequencing
Severe acute respiratory syndrome coronavirus 2 Genome sequencing
Severe acute respiratory syndrome coronavirus 2 Raw sequence reads
Severe acute respiratory syndrome coronavirus 2 Genome sequencing and assembly
To understand the host response to this pathogen, we investigated the gene expression profiles of peripheral blood mononuclear cells (PBMCs) derived from SARS patients, and compared with healthy controls.
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size